Description:
            SWN41522, also known as DUPA and FN11, is a potent Urea-Based Inhibitor of Glutamate Carboxypeptidase II (NAALADase). In vivo antitumor tests using U-87 glioblastoma xenograft showed that FN11 reduced tumor vol. to a value of ∼0.4-0.6 (at 10 or 100 μM) after 4 days treatment, and ∼ 1.0 (at both dosages) after 7 days treatment. The antiangiogenesis activity of FN11 was examd. with similarly grown tumors, and revealed a preponderance of avascular and low vascular areas in tumors treated with FN11 at 100 μM. It was first reported in patent WO 2000064911 and Journal of Medicinal Chemistry (2001), 44(3), 298-301. 
         
    
    
        Handling:
        
            Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months.
            Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, 
            we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one 
            month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at 
            least 1 hour.